Special Call for Research Proposals on COVID-19 in RMDs

Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) first emerged in Wuhan/China leading to a cluster of respiratory infections. The disease caused by SARS-CoV-2 (coronavirus disease 2019, COVID-19) rapidly spreads worldwide. Patients with Rheumatic Musculoskeletal Diseases (RMDs) may be at particular risk for COVID-19 as they show an intrinsically higher risk for infections.

In addition, many of the treatments used for RMDs, such as glucocorticoids or disease modifying anti-rheumatic drugs have the potential to increase infection risk. Therefore, a better mechanistic understanding and clinical knowledge on the impact of COVID-19 in RMD patients is urgently needed.

FOREUM is highly alert to these developments threating patients with RMDs and therefore organizes an ad hoc research campaign to better understand the impact of COVID-19 on RMD patients. To implement this strategy as fast as possible a Special Call for Research Proposals on COVID-19 in RMDs is launched.

Scope
FOREUM seeks to support projects in the following areas:

  • Investigations that provide insights into the clinical course of COVID-19 in patients with RMD compared to non-RMD patients (international registers, cohorts, clinical studies)
  • Projects that address diagnostic and therapeutic challenges of SARS-CoV-2 infection in RMD patients
  • Research on pathogenic mechanisms (e.g. cytokine release syndrome) in the context of COVID-19

Duration
The COVID-19 call is designed to fund a range of research projects. We are especially aiming at projects that provide insight in the short-term while the maximum duration of a project is three years.

Timeline
Closing date for proposals: 7 June 2020
Decisions on proposals announced: 6 July 2020

The call is closed